Poland· PL-100495560

Dorin

A g03aa16, g03hb product containing ethinylestradiolum + dienogestum, registered in Poland by Delfarma Sp. z o.o..

ATC G03AA16, G03HB

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedDorinATCG03AA16, G03HBREGISTER NO.PL-100495560PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

URPL (Poland)
Active substance
Ethinylestradiolum + Dienogestum
Manufacturer
Delfarma Sp. z o.o.
Country
Poland (PL)
ATC code
G03AA16, G03HB
ATC class
G03AA16, G03HB
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991537029
  • gtin
    05909991537036

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ethinylestradiolum + dienogestum in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ethinylestradiolum + dienogestum products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

  • Austria · Dienorette, Dienovel
  • Belgium · Dienobel, Louise
  • Bulgaria · Жанин
  • Czechia · Aidee, Ayreen
  • Germany · Amobena, Aristelle
  • Denmark · Yana
  • Estonia · Ammily, Jeanine
  • Spain · Adieris, Ailyn Diario
  • Finland · Yanulez
  • France · Misolfa
  • United Kingdom (Northern Ireland) · Dienogest/Ethinylestradiol, Serisima
  • Croatia · Donella
  • Hungary · Dienille, Mistral
  • Ireland · Mistra, Raener
  • Italy · Cemisiana, Dienestra
  • Lithuania · Ammily, Jeanine
  • Luxembourg · Dienobel, Louise
  • Latvia · Ammily, Jeanine
  • Netherlands · Ethinylestradiol/Dienogest Mithra, Misolfa
  • Norway · Yana
  • Portugal · Denille, Dienogest + Etinilestradiol Leon Farma
  • Slovakia · Aidee, Dienorette

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/eb248fb5-a440-4eae-9961-65367dd73c72
GET /v1/drugs/eb248fb5-a440-4eae-9961-65367dd73c72?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "0,03 mg + 2 mg",
  "packaging": "05909991537029 ¦ Rp ¦ 154125\n21 tabl.\n05909991537036 ¦ Rp ¦ 154126\n63 tabl.",
  "substance": "Ethinylestradiolum 0.03 mg + Dienogestum 2 mg",
  "common_name": "Ethinylestradiolum + Dienogestum",
  "pl_product_id": "100495560",
  "pozwolenie_nr": "145/24",
  "auth_procedure": "IR",
  "authorisation_validity": "2029-04-09"
}

See everything about ethinylestradiolum + dienogestum.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.